Thu, September 14, 2017
Wed, September 13, 2017
Tue, September 12, 2017
Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017
Tue, September 5, 2017
Fri, September 1, 2017
Thu, August 31, 2017
Wed, August 30, 2017
Tue, August 29, 2017
Mon, August 28, 2017
Fri, August 25, 2017
Thu, August 24, 2017
Wed, August 23, 2017
Tue, August 22, 2017
Mon, August 21, 2017
Fri, August 18, 2017
Thu, August 17, 2017
Wed, August 16, 2017
Tue, August 15, 2017
Mon, August 14, 2017
Fri, August 11, 2017

Alethia Young Maintained (ANAB) at Buy with Increased Target to $38 on, Aug 25th, 2017


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-38-on-aug-25th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Alethia Young of Credit Suisse, Maintained "AnaptysBio, Inc." (ANAB) at Buy with Increased Target from $34 to $38 on, Aug 25th, 2017.

Alethia has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Neena Bitritto-Garg of "Baird" Initiated at Buy and Held Target at $36 on, Tuesday, July 11th, 2017

Publication Contributing Sources